Department of Rare/ Intractable Cancer Analysis Research - Industry-Academia Collaborative Chair - Laboratories | Nagoya University GraduateSchool of Medicine

Laboratories

Back
Top > Laboratories > Industry-Academia Collaborative Chair > Department of Rare/ Intractable Cancer Analysis Research

Industry-Academia Collaborative ChairDepartment of Rare/ Intractable Cancer Analysis Research

 In January 2020, Nagoya University Graduate School of Medicine established a new department for analysis of rare and intractable cancers. This department aims to develop new diagnostic technologies for rare and intractable cancers that have previously been difficult to test using urinary tumor markers.

 The Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, in collaboration with Hitachi Ltd., has been studying cancer testing with urinary tumor markers. As a result, cancer testing models based on comprehensive analysis techniques of urinary metabolites and extraction techniques of urinary tumor markers have shown that cancer patients can be distinguished from healthy individuals in a variety of carcinomas. In addition, we have newly developed a unique method called metabolite panel testing with multiple urinary tumor markers and found that benign tumors can potentially be extracted.
 Through this new effort, this department aims to create a new society that enables early diagnosis of cancer and QoL of patients to be balanced, in collaboration with core hospitals nationwide.